An overview of the hospitals’ antimicrobial stewardship programs implemented to improve antibiotics’ utilization, cost and resistance patterns

Ovais Ullah Shirazi; Norny Syafinaz  Ab Rahman; Che Suraya  Zin

doi:10.31436/jop.v2i1.76

Authors

Ovais Ullah Shirazi Department of Pharmacy Practice, Kulliyyah of Pharmacy, International Islamic University Malaysia, Jalan Sultan Ahmad Shah, 25200 Kuantan, Pahang
Norny Syafinaz Ab Rahman Department of Pharmacy Practice, Kulliyyah of Pharmacy, International Islamic University Malaysia, Jalan Sultan Ahmad Shah, 25200 Kuantan, Pahang
Che Suraya Zin Department of Pharmacy Practice, Kulliyyah of Pharmacy, International Islamic University Malaysia, Jalan Sultan Ahmad Shah, 25200 Kuantan, Pahang

DOI:

https://doi.org/10.31436/jop.v2i1.76

Keywords:

Antimicrobial Stewardship (AMS) Program, Interventions, utilization patterns of antibiotics, cost patterns of antibiotics; infection control, antimicrobial resistance (AMR) Study designs, Antimicrobial Stewardwish (AMS) Program, interventions, utilization patterns of antibiotics, cost patterns of antibiotics, infection control, antimicrobial resistance (AMR) study design

Abstract

Introduction: The high reliance of the physicians and surgeons on the antibiotics since their discovery has led to an irrational antibiotic utilization which not only has raised the incidence of antimicrobial resistance (AMR) but also increased the cost of treatment with antibiotics as high use of antibiotics has been found related to the occurrence of certain nosocomial infections which need extra antibiotic courses to be cured. In order to overcome these antibiotic utilization related problems an antimicrobial stewardship (AMS) program being the set of various persuasive, restrictive and structural interventions is considered an effective tool to rationalize the in-patient antimicrobial utilization worldwide.

Method: The focus of this review is on the interventions that are being implemented during the in-patient AMS programs and have been described effective in controlling the antibiotic utilization, their cost of treatment and an overall infection control. The literature containing the information about various AMS interventions effecting the utilization and cost patterns along with the impact on AMR was searched in various databases such as PubMed, Google Scholar, Science Direct, Ovid (Medline) and Scopus. The categorical sorting of the published data is based on various AMS interventions such as the guideline development, formulary restriction (pre-authorization), educative interventions, clinical pathway development and prospective (post prescription) audit. Considering the objectives of the study such as the goal to curb overutilization of antibiotics, control of their cost of treatment for in-patients and infection control the sorted literature is presented in three different tables describing the AMS impact on the said outcomes.

Results: The post AMS changes in utilization patterns are described as fall of antibiotics defined daily doses (DDD) and days of therapy (DOT) which resulted in the reduction of the cost of treatment with antibiotics. The reduction of the cost of treatment with antibiotics also resulted due to the AMS impact on the control of various nosocomial and multi-drug resistant (MDR) infections.

Conclusion: It has been concluded that the AMS program if implemented under the supervision of an expert AMS team mainly comprising of an infectious disease (ID) physician, clinical pharmacists and microbiologists with considerable support by the hospital authorities could be a highly efficient tool of the pharmacovigilance for rationalizing the in-patient antimicrobial practice.

References

Adhikari, S., Piza, M., Taylor, P., Deshpande, K., Lam, D., & Konecny, P. (2018). Sustained multimodal antimicrobial stewardship in an Australian tertiary intensive care unit from 2008–2015: an interrupted time-series analysis. International Journal of Antimicrobial Agents, 51(4), 620–628.

Al-Omari, A., Al Mutair, A., Alhumaid, S., Salih, S., Alanazi, A., Albarsan, H., Abourayan, M., & Al Subaie, M. (2020). The impact of antimicrobial stewardship program implementation at four tertiary private hospitals: results of a five-years pre-post analysis. Antimicrobial Resistance & Infection Control, 9(1), 95.

Aldeyab, M. A., Harbarth, S., Vernaz, N., Kearney, M. P., Scott, M. G., Darwish Elhajji, F. W., Aldiab, M. A., & McElnay, J. C. (2012). The impact of antibiotic use on the incidence and resistance pattern of extended-spectrum beta-lactamase-producing bacteria in primary and secondary healthcare settings. British Journal of Clinical Pharmacology, 74(1), 171–179.

Apisarnthanarak, A., Kwa, A. L.-H., Chiu, C.-H., Kumar, S., Thu, L. T. A., Tan, B. H., Zong, Z., Chuang, Y. C., Karuniawati, A., Tayzon, M. F., So, T. M.-K., & Peterson, L. R. (2018). Antimicrobial stewardship for acute-care hospitals: An Asian perspective. Infection Control & Hospital Epidemiology, 39(10), 1237–1245.

Ashiru-Oredope, D., Budd, E. L., Bhattacharya, A., Din, N., McNulty, C. A. M., Micallef, C., Ladenheim, D., Beech, E., Murdan, S., & Hopkins, S. (2016). Implementation of antimicrobial stewardship interventions recommended by national toolkits in primary and secondary healthcare sectors in England: TARGET and Start Smart Then Focus. Journal of Antimicrobial Chemotherapy, 71(5), 1408–1414.

Barlam, T. F., Cosgrove, S. E., Abbo, L. M., Macdougall, C., Schuetz, A. N., Septimus, E. J., Srinivasan, A., Dellit, T. H., Falck-Ytter, Y. T., Fishman, N. O., Hamilton, C. W., Jenkins, T. C., Lipsett, P. A., Malani, P. N., May, L. S., Moran, G. J., Neuhauser, M. M., Newland, J. G., Ohl, C. A., Trivedi, K. K. (2016). Implementing an antibiotic stewardship program: Guidelines by the Infectious Diseases Society of America and the Society for Healthcare Epidemiology of America. In Clinical Infectious Diseases, 62 (10), 51-77..

Borde, J. P., Kaier, K., Steib-Bauert, M., Vach, W., Geibel-Zehender, A., Busch, H., Bertz, H., Hug, M., de With, K., & Kern, W. V. (2014). Feasibility and impact of an intensified antibiotic stewardship programme targeting cephalosporin and fluoroquinolone use in a tertiary care university medical center. BMC Infectious Diseases, 14(1).

Box, M. J., Sullivan, E. L., Ortwine, K. N., Parmenter, M. A., Quigley, M. M., Aguilar-Higgins, L. M., Macintosh, C. L., Goerke, K. F., & Lim, R. A. (2015). Outcomes of rapid identification for gram-positive bacteremia in combination with antibiotic stewardship at a community-based hospital system. Pharmacotherapy, 35(3), 269–276.

Boyles, T. H., Naicker, V., Rawoot, N., Raubenheimer, P. J., Eick, B., & Mendelson, M. (2017). Sustained reduction in antibiotic consumption in a South African public sector hospital; Four year outcomes from the Groote Schuur Hospital antibiotic stewardship program. South African Medical Journal, 107(2), 115.

Bruno-Murtha, L. A., Brusch, J., Bor, D., Li, W., & Zucker, D. (2005). A pilot study of antibiotic cycling in the community hospital setting. Infection Control & Hospital Epidemiology, 26(1), 81-87.

Chandrasekhar, D., & PokkaVayalil, V. (2019). Cost minimization analysis on IV to oral conversion of antimicrobial agent by the clinical pharmacist intervention. Clinical Epidemiology and Global Health, 7(1), 60–65.

Chandy, S. J., Naik, G. S., Balaji, V., Jeyaseelan, V., Thomas, K., & Lundborg, C. S. (2014). High cost burden and health consequences of antibiotic resistance: the price to pay. The Journal of Infection in Developing Countries, 8(09), 1096–1102.

Chen, C., Dong, W., Shen, J. J., Cochran, C., Wang, Y., & Hao, M. (2014). Is the prescribing behavior of Chinese physicians driven by financial incentives? Social Science and Medicine, 120, 40–48.

Cisneros, J. M., Neth, O., Gil-Navarro, M. V., Lepe, J. A., Jiménez-Parrilla, F., Cordero, E., Rodríguez-Hernández, M. J., Amaya-Villar, R., Cano, J., Gutiérrez-Pizarraya, A., García-Cabrera, E., & Molina, J. (2014). Global impact of an educational antimicrobial stewardship programme on prescribing practice in a tertiary hospital centre. Clinical Microbiology and Infection, 20(1), 82–88.

Cottagnoud, P., Cottagnoud, M., Acosta, F., & Stucki, A. (2013). Efficacy of Ceftaroline Fosamil against Penicillin-Sensitive and -Resistant Streptococcus pneumoniae in an Experimental Rabbit Meningitis Model. Antimicrobial Agents and Chemotherapy, 57(10), 4653–4655.

Dancer, S. J. (2013). Infection control in the post-antibiotic era. Healthcare infection, 18(2), 51-60.

Day, S. R., Smith, D., Harris, K., Cox, H. L., & Mathers, A. J. (2015). An Infectious diseases physician-led antimicrobial stewardship program at a small community hospital associated with improved susceptibility patterns and cost-savings after the first year. Open Forum Infectious Diseases, 2(2).

Deptu?a, A., Trejnowska, E., Ozorowski, T., & Hryniewicz, W. (2015). Risk factors for healthcare-associated infection in light of two years of experience with the ECDC point prevalence survey of healthcare-associated infection and antimicrobial use in Poland. Journal of Hospital Infection, 90(4), 310–315.

Didiodato, G., McArthur, L., Beyene, J., Smieja, M., & Thabane, L. (2016). Evaluating the impact of an antimicrobial stewardship program on the length of stay of immune-competent adult patients admitted to a hospital ward with a diagnosis of community-acquired pneumonia: A quasi-experimental study. American Journal of Infection Control, 44(5), 73-79.

Du, Y., Li, J., Wang, X., Peng, X., Wang, X., He, W., Li, Y., Wang, X., Yang, Q., & Zhang, X. (2020). Impact of a Multifaceted Pharmacist-Led Intervention on Antimicrobial Stewardship in a Gastroenterology Ward: A Segmented Regression Analysis. Frontiers in Pharmacology, 11.

Dutcher, L., Yeager, A., Gitelman, Y., Morgan, S., Laude, J. D., Binkley, S., Binkley, A., Cimino, C., McDonnell, L., Saw, S., Cluzet, V., Lautenbach, E., & Hamilton, K. W. (2020). Assessing an intervention to improve the safety of automatic stop orders for inpatient antimicrobials. Infection Prevention in Practice, 2(2).

Faraone, A., Poggi, A., Cappugi, C., Tofani, L., Riccobono, E., Giani, T., & Fortini, A. (2020). Inappropriate use of carbapenems in an internal medicine ward: Impact of a carbapenem-focused antimicrobial stewardship program. European Journal of Internal Medicine, 78, 50–57..

Gagliotti, C., Ricchizzi, E., Buttazzi, R., Tumietto, F., Resi, D., & Moro, M. L. (2014). Hospital statistics for antibiotics: defined versus prescribed daily dose. Infection, 42(5), 869-873.

Garcell, H. G., Arias, A. V., Sandoval, C. P., Valle Gamboa, M. E., Sado, A. B., & Alfonso Serrano, R. N. (2017). Impact of a focused antimicrobial stewardship program in adherence to antibiotic prophylaxis and antimicrobial consumption in appendectomies. Journal of Infection and Public Health, 10(4), 415–420.

García-Rodríguez, J. F., Bardán-García, B., Peña-Rodríguez, M. F., Álvarez-Díaz, H., & Mariño-Callejo, A. (2019). Meropenem antimicrobial stewardship program: clinical, economic, and antibiotic resistance impact. European Journal of Clinical Microbiology and Infectious Diseases, 38(1), 161–170.

García-Rodríguez, José Francisco, Bardán-García, B., Juiz-González, P. M., Vilariño-Maneiro, L., Álvarez-Díaz, H., & Mariño-Callejo, A. (2021). Long-Term Carbapenems Antimicrobial Stewardship Program. Antibiotics, 10(1), 15.

Hecker, M. T., Son, A. H., Murphy, N. N., Sethi, A. K., Wilson, B. M., Watkins, R. R., & Donskey, C. J. (2019). Impact of syndrome-specific antimicrobial stewardship interventions on use of and resistance to fluoroquinolones: An interrupted time series analysis. American Journal of Infection Control.

Horikoshi, Y., Suwa, J., Higuchi, H., Kaneko, T., Furuichi, M., Aizawa, Y., Fukuoka, K., Okazaki, K., Ito, K., & Shoji, T. (2017). Sustained pediatric antimicrobial stewardship program with consultation to infectious diseases reduced carbapenem resistance and infection-related mortality. International Journal of Infectious Diseases, 64, 69–73.

Huh, K., Chung, D. R., Park, H. J., Kim, M. J., Lee, N. Y., Ha, Y. E., Kang, C. I., Peck, K. R., & Song, J. H. (2016). Impact of monitoring surgical prophylactic antibiotics and a computerized decision support system on antimicrobial use and antimicrobial resistance. American Journal of Infection Control, 44(9), 145-152.

Kauppinen, H., Ahonen, R., & Timonen, J. (2017). The impact of electronic prescriptions on medication safety in Finnish community pharmacies: A survey of pharmacists. International Journal of Medical Informatics, 100, 56–62.

Khan, H. A., Baig, F. K., & Mehboob, R. (2017). Nosocomial infections: Epidemiology, prevention, control and surveillance. Asian Pacific Journal of Tropical Biomedicine, 7(5), 478–482.

Khdour, M. R., Hallak, H. O., Aldeyab, M. A., Nasif, M. A., Khalili, A. M., Dallashi, A. A., Khofash, M. B., & Scott, M. G. (2018). Impact of antimicrobial stewardship programme on hospitalized patients at the intensive care unit: a prospective audit and feedback study. British Journal of Clinical Pharmacology, 84(4), 708–715.

Knight, J., Michal, J., Milliken, S., & Swindler, J. (2020). Effects of a Remote Antimicrobial Stewardship Program on Antimicrobial Use in a Regional Hospital System. Pharmacy, 8(1), 41.

Knox, J. F., & Wiemiller, M. J. P. (2017). Antibiotic Stewardship Choosing Wisely. In Physician Assistant Clinics, 2(3), 489–501

Lanbeck, P., Ragnarson Tennvall, G., & Resman, F. (2016). A cost analysis of introducing an infectious disease specialist-guided antimicrobial stewardship in an area with relatively low prevalence of antimicrobial resistance. BMC Health Services Research, 16(1).

Lawes, T., Lopez-Lozano, J. M., Nebot, C. A., Macartney, G., Subbarao-Sharma, R., Dare, C. R. J., Wares, K. D., & Gould, I. M. (2015). Effects of national antibiotic stewardship and infection control strategies on hospital-associated and community-associated meticillin-resistant Staphylococcus aureus infections across a region of Scotland: A non-linear time-series study. The Lancet Infectious Diseases, 15(12), 1438–1449.

Lee, T. C., Frenette, C., Jayaraman, D., Green, L., & Pilote, L. (2014). Antibiotic self-stewardship: Trainee-led structured antibiotic time-outs to improve antimicrobial use. Annals of Internal Medicine, 161, 53-58.

Lesprit, P., de Pontfarcy, A., Esposito-Farese, M., Ferrand, H., Mainardi, J. L., Lafaurie, M., Parize, P., Rioux, C., Tubach, F., & Lucet, J. C. (2015). Postprescription review improves in-hospital antibiotic use: A multicenter randomized controlled trial. Clinical Microbiology and Infection, 21(2), 180-187.

Lester, R., Haigh, K., Wood, A., MacPherson, E. E., Maheswaran, H., Bogue, P., Hanger, S., Kalizang’oma, A., Srirathan, V., Kulapani, D., Mallewa, J., Nyirenda, M., Jewell, C. P., Heyderman, R., Gordon, M., Lalloo, D. G., Tolhurst, R., & Feasey, N. A. (2020). Sustained Reduction in Third-generation Cephalosporin Usage in Adult Inpatients Following Introduction of an Antimicrobial Stewardship Program in a Large, Urban Hospital in Malawi. Clinical Infectious Diseases.

Libertin, C. R., Watson, S. H., Tillett, W. L., & Peterson, J. H. (2017). Dramatic effects of a new antimicrobial stewardship program in a rural community hospital. American Journal of Infection Control, 45(9), 979–982.

Livermore, D. M., Hope, R., Reynolds, R., Blackburn, R., Johnson, A. P., & Woodford, N. (2013). Declining cephalosporin and fluoroquinolone non-susceptibility among bloodstream Enterobacteriaceae from the UK: links to prescribing change? Journal of Antimicrobial Chemotherapy, 68(11), 2667–2674.

Mardani, M., Abolghasemi, S., & Shabani, S. (2020). Impact of an antimicrobial stewardship program in the antimicrobial-resistant and prevalence of clostridioides difficile infection and amount of antimicrobial consumed in cancer patients. BMC Research Notes, 13(1), 246.

Mendem, S. K., Alasthimannahalli Gangadhara, T., Shivannavar, C. T., & Gaddad, S. M. (2016). Antibiotic resistance patterns of Staphylococcus aureus: A multi center study from India. Microbial Pathogenesis, 98, 167–170.

Miliani, K., L’Hériteau, F., Lacavé, L., Carbonne, A., & Astagneau, P. (2011). Imipenem and ciprofloxacin consumption as factors associated with high incidence rates of resistant Pseudomonas aeruginosa in hospitals in northern France. Journal of Hospital Infection, 77(4), 343–347.

Murri, R., Taccari, F., Spanu, T., D’Inzeo, T., Mastrorosa, I., Giovannenze, F., Scoppettuolo, G., Ventura, G., Palazzolo, C., Camici, M., Lardo, S., Fiori, B., Sanguinetti, M., Cauda, R., & Fantoni, M. (2018). A 72-h intervention for improvement of the rate of optimal antibiotic therapy in patients with bloodstream infections. European Journal of Clinical Microbiology and Infectious Diseases, 37(1), 167–173.

Neo, J. R. J., Niederdeppe, J., Vielemeyer, O., Lau, B., Demetres, M., & Sadatsafavi, H. (2020). Evidence-Based Strategies in Using Persuasive Interventions to Optimize Antimicrobial Use in Healthcare: a Narrative Review. Journal of Medical Systems, 44(3), 64.

Nilholm, H., Holmstrand, L., Ahl, J., Månsson, F., Odenholt, I., Tham, J., Melander, E., & Resman, F. (2015). An audit-based, infectious disease specialist-guided antimicrobial stewardship program profoundly reduced antibiotic use without negatively affecting patient outcomes. Open Forum Infectious Diseases, 2(2).

O’Driscoll, T., & Crank, C. W. (2015). Vancomycin-resistant enterococcal infections: epidemiology, clinical manifestations, and optimal management. Infection and Drug Resistance, 8, 217–230.

Okumura, L. M., da Silva, M. M. G., & Veroneze, I. (2015). Effects of a bundled Antimicrobial Stewardship Program on mortality: A cohort study. Brazilian Journal of Infectious Diseases, 19(3), 246–252.

Palmay, L., Elligsen, M., Walker, S. A. N., Pinto, R., Walker, S., Einarson, T., Simor, A., Rachlis, A., Mubareka, S., & Daneman, N. (2014). Hospital-wide rollout of antimicrobial stewardship: A stepped-wedge randomized trial. Clinical Infectious Diseases, 59(6), 867–874.

Pardo, J., Klinker, K. P., Borgert, S. J., Butler, B. M., Giglio, P. G., & Rand, K. H. (2016). Clinical and economic impact of antimicrobial stewardship interventions with the FilmArray blood culture identification panel. Diagnostic Microbiology and Infectious Disease, 84(2), 159–164.

Paulson, C. M., Handley, J. F., Dilworth, T. J., Persells, D., Prusi, R. Y., Brummitt, C. F., Torres, K. M., & Skrupky, L. P. (2020). Impact of a Systematic Pharmacist-Initiated Antibiotic Time-Out Intervention for Hospitalized Adults. Journal of Pharmacy Practice.

Peragine, C., Walker, S. A. N., Simor, A., Walker, S. E., Kiss, A., & Leis, J. A. (2020). Impact of a Comprehensive Antimicrobial Stewardship Program on Institutional Burden of Antimicrobial Resistance: A 14-Year Controlled Interrupted Time-series Study. Clinical Infectious Diseases, 71(11), 2897–2904.

Percival, K. M., Valenti, K. M., Schmittling, S. E., Strader, B. D., Lopez, R. R., & Bergman, S. J. (2015). Impact of an antimicrobial stewardship intervention on urinary tract infection treatment in the ED. American Journal of Emergency Medicine, 33(9), 1129–1133.

Phoon, H. Y. P., Hussin, H., Hussain, B. M., Lim, S. Y., Woon, J. J., Er, Y. X., & Thong, K. L. (2018). Distribution, genetic diversity and antimicrobial resistance of clinically important bacteria from the environment of a tertiary hospital in Malaysia. Journal of Global Antimicrobial Resistance, 14, 132–140.

Pineda, R., Kanatani, M., & Deville, J. (2020). 102. Effects of an Antimicrobial Stewardship-guided MRSA Nasal Screening Review on Vancomycin Utilization for Respiratory Infections: A Quasi-Experimental Study. Open Forum Infectious Diseases, 7(1), 65.

Pitiriga, V., Kanellopoulos, P., Kampos, E., Panagiotakopoulos, G., Tsakris, A., & Saroglou, G. (2018). Antimicrobial stewardship program in a Greek hospital: Implementing a mandatory prescription form and prospective audits. Future Microbiology, 13(8), 889–896.

Ruiz, J., Salavert, M., Ramirez, P., Montero, M., Castro, I., Gonzalez, E., Roma, E., & Poveda, J. L. (2018). [Antimicrobial stewardship programme implementation in a medical ward]. Revista Espanola de Quimioterapia?: Publicacion Oficial de La Sociedad Espanola de Quimioterapia, 31(5), 419–426.

Sadiq, M. B., Syed-Hussain, S. S., Ramanoon, S. Z., Saharee, A. A., Ahmad, N. I., Noraziah, M. Z., Khalid, S. F., Naseeha, D. S., Syahirah, A. A., & Mansor, R. (2018). Knowledge, attitude and perception regarding antimicrobial resistance and usage among ruminant farmers in Selangor, Malaysia. Preventive Veterinary Medicine, 156, 76–83.

Seah, V. X. F., Ong, R. Y. L., Lim, A. S. Y., Chong, C. Y., Tan, N. W. H., & Thoon, K. C. (2017). Impact of a Carbapenem Antimicrobial Stewardship Program on Patient Outcomes. Antimicrobial Agents and Chemotherapy, 61(9).

Seah, X. F. V., Ong, Y. L. R., Tan, S. W., Krishnaswamy, G., Chong, C. Y., Tan, N. W. H., & Thoon, K. C. (2014). Impact of an antimicrobial stewardship program on the use of carbapenems in a tertiary Women’s and Children’s Hospital, Singapore. Pharmacotherapy, 34(11), 1141–1150.

Shively, N. R., Moffa, M. A., Paul, K. T., Wodusky, E. J., Schipani, B. A., Cuccaro, S. L., Harmanos, M. S., Cratty, M. S., Chamovitz, B. N., & Walsh, T. L. (2020). Impact of a Telehealth-Based Antimicrobial Stewardship Program in a Community Hospital Health System. Clinical Infectious Diseases, 71(3), 539–545.

So, M., Mamdani, M. M., Morris, A. M., Lau, T. T. Y., Broady, R., Deotare, U., Grant, J., Kim, D., Schimmer, A. D., Schuh, A. C., Shajari, S., Steinberg, M., Bell, C. M., & Husain, S. (2018). Effect of an antimicrobial stewardship programme on antimicrobial utilisation and costs in patients with leukaemia: a retrospective controlled study. Clinical Microbiology and Infection, 24(8), 882–888.

Strazzulla, A., Bokobza, S., Ombandza, E., Kherallah, K., Hommel, S., Draidi, R., Bonutto, C., Zamponi, D. B., Gauzit, R., & Diamantis, S. (2020). Impact of an Antimicrobial Stewardship Program on Resistance to Fluoroquinolones of Urinary Enterobacteriaceae Isolated From Nursing Home Residents: A Retrospective Cohort Study. Journal of the American Medical Directors Association, 21(9), 1322–1326.

Surat, G., Vogel, U., Wiegering, A., Germer, C.-T., & Lock, J. F. (2021). Defining the Scope of Antimicrobial Stewardship Interventions on the Prescription Quality of Antibiotics for Surgical Intra-Abdominal Infections. Antibiotics, 10(1), 73.

Suwantarat, N., & Carroll, K. C. (2016). Epidemiology and molecular characterization of multidrug-resistant Gram-negative bacteria in Southeast Asia. Antimicrobial Resistance and Infection Control, 5(1).

Tang, S. J., Gupta, R., Lee, J. I., Majid, A. M., Patel, P., Efird, L., Loo, A., Mazur, S., Calfee, D. P., Archambault, A., Jannat-Khah, D., Dargar, S. K., & Simon, M. S. (2018). Impact of Hospitalist-Led Interdisciplinary Antimicrobial Stewardship Interventions at an Academic Medical Center. Joint Commission Journal on Quality and Patient Safety.

Tartof, S. Y., Chen, L. H., Tian, Y., Wei, R., Im, T., Yu, K., Rieg, G., Bider-Canfield, Z., Wong, F., Takhar, H. S., & Qian, L. (2020). Do Inpatient Antimicrobial Stewardship Programs help us in the Battle against Antimicrobial Resistance? Clinical Infectious Diseases.

Tedeschi, S., Trapani, F., Giannella, M., Cristini, F., Tumietto, F., Bartoletti, M., Liverani, A., Pignanelli, S., Toni, L., Pederzini, R., Cavina, A., & Viale, P. (2017). An Antimicrobial Stewardship Program Based on Systematic Infectious Disease Consultation in a Rehabilitation Facility. Infection Control and Hospital Epidemiology, 38(1), 76–82.

Teixeira Rodrigues, A., Roque, F., Piñeiro-Lamas, M., Falcão, A., Figueiras, A., & Herdeiro, M. T. (2019). Effectiveness of an intervention to improve antibiotic-prescribing behaviour in primary care: a controlled, interrupted time-series study. Journal of Antimicrobial Chemotherapy, 74(9), 2788–2796.

Thampi, N., Shah, P. S., Nelson, S., Agarwal, A., Steinberg, M., Diambomba, Y., & Morris, A. M. (2019). Prospective audit and feedback on antibiotic use in neonatal intensive care: a retrospective cohort study. BMC Pediatrics, 19(1), 105.

Trupka, T., Fisher, K., Micek, S. T., Juang, P., & Kollef, M. H. (2017). Enhanced antimicrobial de-escalation for pneumonia in mechanically ventilated patients: A cross-over study. Critical Care, 21(1).

Wang, H. Y., Chiu, C. H., Huang, C. T., Cheng, C. W., Lin, Y. J., Hsu, Y. J., Chen, C. H., Deng, S. T., & Leu, H. S. (2014). Blood culture-guided de-escalation of empirical antimicrobial regimen for critical patients in an online antimicrobial stewardship programme. International Journal of Antimicrobial Agents, 44(6), 520–527.

Waters, C. D. (2015). Pharmacist-driven antimicrobial stewardship program in an institution without infectious diseases physician support. American Journal of Health-System Pharmacy, 72(6), 466–468.

Wenisch, J. M., Equiluz-Bruck, S., Fudel, M., Reiter, I., Schmid, A., Singer, E., & Chott, A. (2014). Decreasing Clostridium difficile Infections by an Antimicrobial Stewardship Program That Reduces Moxifloxacin Use. Antimicrobial Agents and Chemotherapy, 58(9), 5079–5083.

Yusef, D., Hayajneh, W. A., Bani Issa, A., Haddad, R., Al-Azzam, S., Lattyak, E. A., Lattyak, W. J., Gould, I., Conway, B. R., Bond, S., Conlon-Bingham, G., & Aldeyab, M. A. (2021). Impact of an antimicrobial stewardship programme on reducing broad-spectrum antibiotic use and its effect on carbapenem-resistant Acinetobacter baumannii (CRAb) in hospitals in Jordan. Journal of Antimicrobial Chemotherapy, 76(2), 516–523.